Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 8.3B | 8.4B | 7.9B | 8.6B |
Cost of revenue | 2.8B | 2.9B | 2.8B | 3.0B |
Gross profit | 5.5B | 5.5B | 5.2B | 5.5B |
Operating expense | ||||
Research & development | 675M | 697M | 676M | 675M |
Selling general and admin | 2.7B | 2.8B | 2.7B | 2.8B |
Other operating expenses | -5M | -34M | 1M | 477M |
Operating income | 1.7B | 1.6B | 1.4B | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 179M | 209M | 167M | 202M |
Other income expense | 7M | 143M | 29M | -151M |
Pretax income | 1.5B | 1.6B | 1.3B | 855M |
Tax provision | 237M | 281M | 220M | 197M |
Net income | 1.3B | 1.3B | 1.0B | 660M |
Basic EPS | 1.0 | 1.0 | 0.8 | 0.5 |
Diluted EPS | 1.0 | 1.0 | 0.8 | 0.5 |
Basic average shares | 1.5B | 1.5B | 1.5B | 1.5B |
Diluted average shares | 1.5B | 1.5B | 1.5B | 1.5B |
EBITDA | 2.5B | 2.5B | 2.2B | 1.9B |
Net income from continuing op. | 1.3B | 1.3B | 1.0B | 660M |
Minority interests | -9M | -9M | -6M | -5M |
Preferred stock dividends | — | — | — | — |